Claudio Papi

4.0k total citations
84 papers, 2.3k citations indexed

About

Claudio Papi is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Claudio Papi has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Genetics, 59 papers in Epidemiology and 39 papers in Surgery. Recurrent topics in Claudio Papi's work include Inflammatory Bowel Disease (74 papers), Microscopic Colitis (55 papers) and Diverticular Disease and Complications (10 papers). Claudio Papi is often cited by papers focused on Inflammatory Bowel Disease (74 papers), Microscopic Colitis (55 papers) and Diverticular Disease and Complications (10 papers). Claudio Papi collaborates with scholars based in Italy, Lebanon and Canada. Claudio Papi's co-authors include Lucio Capurso, M. Koch, Annalisa Aratari, A Ciaco, R. Caprilli, Angelo Viscido, Vito Annese, Alessandra Moretti, Roberto Luchetti and Livia Biancone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Claudio Papi

82 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Claudio Papi 1.6k 1.4k 1.0k 173 171 84 2.3k
Francisco Portela 1.3k 0.8× 1.0k 0.8× 929 0.9× 163 0.9× 167 1.0× 129 2.1k
Jasbir Dhaliwal 1.5k 0.9× 1.2k 0.9× 709 0.7× 207 1.2× 228 1.3× 22 2.0k
Amanda Ricciuto 1.7k 1.1× 1.3k 0.9× 849 0.8× 200 1.2× 282 1.6× 44 2.4k
Kerri L. Novak 1.8k 1.1× 1.4k 1.0× 939 0.9× 169 1.0× 187 1.1× 111 2.4k
Henit Yanai 1.8k 1.2× 1.3k 0.9× 923 0.9× 436 2.5× 600 3.5× 125 2.6k
Antonio Rispo 1.5k 1.0× 1.5k 1.1× 1.1k 1.1× 667 3.9× 132 0.8× 125 2.5k
Fernando Bermejo 1.3k 0.8× 1.0k 0.7× 1.3k 1.2× 401 2.3× 387 2.3× 137 2.8k
Ayanna Lewis 1.3k 0.9× 998 0.7× 552 0.5× 174 1.0× 179 1.0× 10 1.5k
Kang‐Moon Lee 943 0.6× 837 0.6× 1.0k 1.0× 287 1.7× 347 2.0× 173 2.4k
Christina Ha 1.1k 0.7× 794 0.6× 538 0.5× 167 1.0× 213 1.2× 103 1.8k

Countries citing papers authored by Claudio Papi

Since Specialization
Citations

This map shows the geographic impact of Claudio Papi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Papi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Papi more than expected).

Fields of papers citing papers by Claudio Papi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Papi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Papi. The network helps show where Claudio Papi may publish in the future.

Co-authorship network of co-authors of Claudio Papi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Papi. A scholar is included among the top collaborators of Claudio Papi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Papi. Claudio Papi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ratajczak, Alicja Ewa, Stefano Festa, Annalisa Aratari, et al.. (2023). Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review. Frontiers in Nutrition. 9. 1088693–1088693. 27 indexed citations
3.
Furfaro, Federica, Ferdinando D’Amico, Alessandra Zilli, et al.. (2022). Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 21(12). 3143–3151. 18 indexed citations
4.
Festa, Stefano, Maria Lia Scribano, Daniela Pugliese, et al.. (2020). Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study. United European Gastroenterology Journal. 9(4). 507–516. 25 indexed citations
5.
Zerboni, Giulia, et al.. (2019). L’importanza del coinvolgimento attivo del paziente nella gestione delle malattie infiammatorie croniche dell’intestino. Recenti Progressi in Medicina. 110(5). 236–243. 1 indexed citations
6.
Cantoro, Laura, Marco Vincenzo Lenti, Rita Monterubbianesi, et al.. (2019). Early‐onset versus late‐onset Crohn’s disease: An Italian cohort study. United European Gastroenterology Journal. 8(1). 52–58. 12 indexed citations
7.
Pugliese, Daniela, Annalisa Aratari, Stefano Festa, et al.. (2018). Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study. Gastroenterology Research and Practice. 2018. 1–7. 8 indexed citations
8.
Gionchetti, Paolo, Fernando Rizzello, Vito Annese, et al.. (2017). Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Digestive and Liver Disease. 49(6). 604–617. 44 indexed citations
9.
Cesarini, Monica, Stefano Festa, & Claudio Papi. (2016). Methotrexate in Crohn’s disease: a new face for an old drug?. Expert Review of Gastroenterology & Hepatology. 10(10). 1135–1144. 4 indexed citations
10.
Aratari, Annalisa, et al.. (2016). Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?. Digestive and Liver Disease. 48(4). 371–375. 17 indexed citations
11.
Monterubbianesi, Rita, Claudio Papi, & Anna Kohn. (2015). P529. Maintenance of clinical remission in Crohn's disease patients after discontinuation of antiTNF agents: Results from a single centre cohort. Journal of Crohn s and Colitis. 9(suppl 1). S345–S345. 4 indexed citations
12.
Aratari, Annalisa, et al.. (2014). Impatto dei fattori ambientali sul decorso delle malattie infiammatorie croniche dell’intestino: quali evidenze?. Recenti Progressi in Medicina. 105(12). 473–8. 2 indexed citations
13.
Armuzzi, Alessandro, Gabriele Riegler, Monia Baldoni, et al.. (2014). P629 Epidemiological features and disease related concerns of a large cohort of Italian patients with active Crohn's disease. Journal of Crohn s and Colitis. 8. S332–S332. 2 indexed citations
14.
Biancone, Livia, C. Petruzziello, Ambrogio Orlando, et al.. (2010). Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study. Inflammatory Bowel Diseases. 17(3). 758–766. 35 indexed citations
15.
Cottone, Mario, Anna Kohn, Marco Daperno, et al.. (2010). Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 9(1). 30–35. 260 indexed citations
16.
Papi, Claudio, Annalisa Aratari, Valentina Tornatore, et al.. (2009). Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine. Journal of Crohn s and Colitis. 3(2). 109–114. 7 indexed citations
17.
Moretti, Alessandra, Claudio Papi, Annalisa Aratari, et al.. (2008). Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis?. Digestive and Liver Disease. 40(5). 379–385. 46 indexed citations
18.
Aratari, Annalisa, Angelo Viscido, Adriana Marcheggiano, et al.. (2006). Mucosal features and granulocyte–monocyte-apheresis in steroid-dependent/refractory ulcerative colitis. Digestive and Liver Disease. 38(6). 389–394. 19 indexed citations
19.
Caprilli, R., Emanuele Angelucci, Angelo Viscido, et al.. (2005). Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Digestive and Liver Disease. 37(6). 407–417. 26 indexed citations
20.
Caprilli, R., Mario Cottone, Francesco Tonelli, et al.. (2003). Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial. Alimentary Pharmacology & Therapeutics. 17(4). 517–523. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Portela Breakdown of academic impact, for papers by Jasbir Dhaliwal Breakdown of academic impact, for papers by Amanda Ricciuto Breakdown of academic impact, for papers by Kerri L. Novak Breakdown of academic impact, for papers by Henit Yanai Breakdown of academic impact, for papers by Antonio Rispo Breakdown of academic impact, for papers by Fernando Bermejo Breakdown of academic impact, for papers by Ayanna Lewis Breakdown of academic impact, for papers by Kang‐Moon Lee Breakdown of academic impact, for papers by Christina Ha
Rankless by CCL
2026